E&Investment, Inc.

Insider Reports History

Entity
Company
Location
16 Th Floor, Yeoksam I Tower, B/D 326, Teheran Ro, Gangnam Gu, Seoul, Korea, Republic of
Signature
/s/ E&I Investment, Inc., By: Na Yeon Kim, CEO
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by E&Investment, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 2.89M $9.05M $3.13 Jul 26, 2022 Held by The E&Healthcare Investment Fund II
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 1.86M $5.84M $3.13 Jul 26, 2022 Held by The E&Healthcare Investment Fund No. 7
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 1.12M $3.51M $3.13 Jul 26, 2022 Held by The E&Healthcare Investment Fund No. 6
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 140K $439K $3.13 Jul 26, 2022 Direct

Insider Reports Filed by E&Investment, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRBO NeuroBo Pharmaceuticals, Inc. Jul 26, 2022 1 $0 4 Jul 28, 2022 10%+ Owner